Keyword Analysis & Research: assembly biosciences


Keyword Analysis

Keyword CPC PCC Volume Score Length of keyword
assembly biosciences0.680.810989020
assembly0.290.2675478
biosciences1.020.538823411

Keyword Research: People who searched assembly biosciences also searched

Keyword CPC PCC Volume Score
assembly biosciences1.980.9994896
assembly biosciences stock0.020.335353
assembly biosciences aktie0.510.590641
assembly biosciences news0.620.4957022
assembly biosciences nasdaq1.780.2510284
assembly biosciences stocktwits1.190.5606180
assembly biosciences groton ct1.931591470
assembly biosciences ir0.560.8309823
assembly biosciences presentation1.410.9409964
assembly biosciences buyout0.481982049
assembly biosciences aktie ig0.370.790399
assembly biosciences stock price1.130.620760
assembly biosciences corporate presentation1.470.4364941
assembly biosciences inc0.330.4416899
tim myott assembly biosciences1.450.749814
assembly biosciences address0.480.378677
assembly biosciences hbv0.870.771076
assembly biosciences ticker0.770.1103785

Search Results related to assembly biosciences on Search Engine

  • Home - Assembly Bio : Assembly Bio

    assemblybio.com

    https://www.assemblybio.com/

    WEBAssembly Bio is applying our passion, scientific ingenuity and deep knowledge of virology to pursue novel antivirals with the potential to change the paradigm for the treatment of serious diseases. Our ambitious and compassionate work has …

    DA: 84 PA: 17 MOZ Rank: 22

  • Gilead and Assembly Biosciences Establish Partnership to …

    gilead.com

    https://www.gilead.com/news-and-press/press-room/press-releases/2023/10/gilead-and-assembly-biosciences-establish-partnership-to-develop-next-generation-therapeutics-for-serious-viral-diseases

    WEBOct 17, 2023 · Led by an accomplished team of leaders in virologic drug development, Assembly Bio is committed to improving outcomes for patients struggling with the serious, chronic impacts of herpesvirus, hepatitis B virus (HBV) and hepatitis delta virus (HDV) infections. For more information, visit Assemblybio.com .

    DA: 71 PA: 100 MOZ Rank: 84

  • About - Assembly Bio : Assembly Bio

    assemblybio.com

    https://www.assemblybio.com/about/

    WEBAssembly Bio is an ambitious biopharmaceutical company with cutting-edge therapeutic clinical candidates capable of improving the lives of millions living with chronic hepatitis B virus (HBV) infection around the world, and research and preclinical programs focused on the discovery of novel antivirals to treat devastating viral diseases, includi...

    DA: 95 PA: 3 MOZ Rank: 67

  • Investor Relations : Assembly Biosciences, Inc.

    assemblybio.com

    https://investor.assemblybio.com/

    WEBOct 17, 2023 · Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights. Assembly Biosciences Announces Effective Date of Reverse Stock Split. Assembly Biosciences Provides Anticipated Development Milestones for 2024.

    DA: 66 PA: 64 MOZ Rank: 98

  • Assembly Biosciences Provides Anticipated Development …

    assemblybio.com

    https://www.assemblybio.com/news/assembly-biosciences-provides-anticipated-development-milestones-for-2024/

    WEBJan 4, 2024 · SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today provided an outline of the anticipated milestones and progress for its clinical pipeline during 2024.

    DA: 34 PA: 11 MOZ Rank: 86


  • Assembly Biosciences to Highlight Pipeline Progress in HBV and …

    assemblybio.com

    https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-highlight-pipeline-progress-hbv-and-hdv

    WEBSep 19, 2023 · SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced that the company will present new preclinical data from multiple hepatitis B virus (HBV) and …

    DA: 23 PA: 66 MOZ Rank: 74

  • Assembly Biosciences Reports First Quarter 2022 Financial …

    assemblybio.com

    https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-reports-first-quarter-2022-financial

    WEBMay 12, 2022 · SOUTH SAN FRANCISCO, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics targeting hepatitis B virus (HBV) and other viral diseases, today reported financial results and recent highlights for the first quarter …

    DA: 90 PA: 13 MOZ Rank: 91

  • Assembly Biosciences Reports Third Quarter 2022 Financial …

    assemblybio.com

    https://www.assemblybio.com/news/assembly-biosciences-reports-third-quarter-2022-financial-results-and-recent-highlights-and-announces-upcoming-conference-participation/

    WEBSOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative, investigational therapeutics targeting hepatitis B virus (HBV) and other viral diseases, today announced financial results and recent highlights for the third quarter …

    DA: 19 PA: 88 MOZ Rank: 87

  • Assembly Biosciences Presents New Data Highlighting Entry …

    assemblybio.com

    https://investor.assemblybio.com/news-releases/news-release-details/assembly-biosciences-presents-new-data-highlighting-entry

    WEBJun 21, 2023 · SOUTH SAN FRANCISCO, Calif., June 21, 2023 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative antiviral therapeutics targeting serious viral diseases, today announced data from its hepatitis D virus (HDV) and hepatitis B virus (HBV) antiviral pipeline featured in five …

    DA: 71 PA: 100 MOZ Rank: 3

  • Assembly Biosciences, Inc. | LinkedIn

    linkedin.com

    https://www.linkedin.com/company/assembly-bio

    WEBAssembly Biosciences is a biotechnology company dedicated to the development of innovative small molecule antiviral therapeutics designed to change the path of serious viral diseases and...

    DA: 39 PA: 29 MOZ Rank: 19